ZA200806320B - Diazepinones - Google Patents

Diazepinones

Info

Publication number
ZA200806320B
ZA200806320B ZA200806320A ZA200806320A ZA200806320B ZA 200806320 B ZA200806320 B ZA 200806320B ZA 200806320 A ZA200806320 A ZA 200806320A ZA 200806320 A ZA200806320 A ZA 200806320A ZA 200806320 B ZA200806320 B ZA 200806320B
Authority
ZA
South Africa
Prior art keywords
diazepinones
Prior art date
Application number
ZA200806320A
Other languages
English (en)
Inventor
Melanie Schultz
Lars Thore Burgdorf
Dirk Finsinger
Andree Blaukat
Hartmut Greiner
Christina Esdar
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA200806320B publication Critical patent/ZA200806320B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200806320A 2005-12-22 2008-07-21 Diazepinones ZA200806320B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005061655A DE102005061655A1 (de) 2005-12-22 2005-12-22 Diazepinone

Publications (1)

Publication Number Publication Date
ZA200806320B true ZA200806320B (en) 2009-12-30

Family

ID=37875481

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200806320A ZA200806320B (en) 2005-12-22 2008-07-21 Diazepinones

Country Status (14)

Country Link
US (1) US7943608B2 (fr)
EP (1) EP1966212B1 (fr)
JP (1) JP5323494B2 (fr)
KR (1) KR20080080658A (fr)
CN (1) CN101341151A (fr)
AR (1) AR058398A1 (fr)
AU (1) AU2006334820B2 (fr)
BR (1) BRPI0620090A2 (fr)
CA (1) CA2634555C (fr)
DE (1) DE102005061655A1 (fr)
EA (1) EA200801425A1 (fr)
IL (1) IL192285A (fr)
WO (1) WO2007079826A1 (fr)
ZA (1) ZA200806320B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3828185A3 (fr) * 2009-01-06 2021-09-01 Dana Farber Cancer Institute, Inc. Composés d'échafaudage de kinase pyrimido-diazépinone et procédés de traitement de troubles
WO2011082269A2 (fr) 2009-12-30 2011-07-07 Arqule, Inc. Composés de benzo-pyrimido-tétrazolo-diazépine substituée
DE102010047069A1 (de) * 2010-10-01 2012-04-05 Universitätsklinikum Kiel Schleswig-Holstein Differenzialdiagnostik von Pankreasadenomen
TW201632520A (zh) 2014-11-25 2016-09-16 拜耳製藥股份有限公司 經取代之吡啶並苯並二氮呯酮衍生物及其用途
AR103598A1 (es) 2015-02-02 2017-05-24 Forma Therapeutics Inc Ácidos bicíclicos[4,6,0]hidroxámicos como inhibidores de hdac
AU2016215432B2 (en) 2015-02-02 2020-07-30 Valo Early Discovery, Inc. 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
MX2018004977A (es) * 2015-10-23 2018-07-06 Sunesis Pharmaceuticals Inc Inhibidores heterociclicos de la proteina cinasa 1 dependiente de 3-fosfoinositido (pdk1) para usarse en el tratamiento del cancer.
US10555935B2 (en) 2016-06-17 2020-02-11 Forma Therapeutics, Inc. 2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors
CN115282282B (zh) * 2021-09-08 2024-01-09 北京大学人民医院 靶向pdk1调控糖代谢重编程联合二甲双胍在子宫内膜癌合并糖尿病患者治疗的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880855A (en) * 1973-04-16 1975-04-29 Bristol Myers Co 5,6-DIHYDRO-11-H-pyrimido{8 4,5-b{9 {8 1,4{9 benzodiazepines
US3872122A (en) 1973-04-16 1975-03-18 Bristol Myers Co 11 H-Pyrimido{8 4,5-b{9 {8 1,4{9 benzodiazepines
EP0024582A1 (fr) * 1979-08-10 1981-03-11 Byk Gulden Lomberg Chemische Fabrik GmbH Benzodiazépinones, procédé pour leur préparation et médicaments les contenant
CA2515790C (fr) * 2003-02-27 2012-11-27 Abbott Laboratories Inhibiteurs de kinase heterocyclique

Also Published As

Publication number Publication date
AU2006334820B2 (en) 2012-11-29
JP5323494B2 (ja) 2013-10-23
IL192285A (en) 2014-11-30
CN101341151A (zh) 2009-01-07
EP1966212B1 (fr) 2015-05-13
DE102005061655A1 (de) 2007-06-28
JP2009520709A (ja) 2009-05-28
IL192285A0 (en) 2008-12-29
US7943608B2 (en) 2011-05-17
WO2007079826A1 (fr) 2007-07-19
AU2006334820A1 (en) 2007-07-19
CA2634555A1 (fr) 2007-07-19
EP1966212A1 (fr) 2008-09-10
AR058398A1 (es) 2008-01-30
EA200801425A1 (ru) 2008-12-30
KR20080080658A (ko) 2008-09-04
US20080318934A1 (en) 2008-12-25
BRPI0620090A2 (pt) 2011-11-01
CA2634555C (fr) 2014-07-15

Similar Documents

Publication Publication Date Title
DE502006001600D1 (en) Pyrazolylcarboxanilide
IL191636A0 (en) Neuropeptide-2 receptor-agonists
GB2440699B (en) Combination dolly-pallet
DE602006003064D1 (en) Tripeptid- und tetrapeptid-thioether
DE502005007477D1 (en) Delta-sigma-modulator
ZA200806320B (en) Diazepinones
GB0523041D0 (en) Combination
GB0523040D0 (en) Combination
DE502006002219D1 (en) Rotationspumpe
EP1954133A4 (fr) Pyrrolidine-anilines
DE502006004337D1 (en) Strangführungsrolle
DE502006007734D1 (en) Thiazolcarbonsäureanilide
GB0524349D0 (en) Stratecut
GB0523623D0 (en) Ezi-wheels
GB0511513D0 (en) Ablu
AU3292P (en) DP303 Dianella prunina
AU3685P (en) DOW10 Tristaniopsis laurina
AU3621P (en) Scacover Scaevola aemula
AU3401P (en) Archise Arctotis fastuosa
AU4036P (en) Dottie Calathea roseo-picta
AU3393P (en) Breakwell xTriticosecale
GB0523160D0 (en) Combination
GB0508237D0 (en) Combination
GB0501935D0 (en) Shelfmate
AU302343S (en) Lockclip